151 related articles for article (PubMed ID: 16002796)
1. Folic acid supplementation for 3 wk reduces pulse pressure and large artery stiffness independent of MTHFR genotype.
Williams C; Kingwell BA; Burke K; McPherson J; Dart AM
Am J Clin Nutr; 2005 Jul; 82(1):26-31. PubMed ID: 16002796
[TBL] [Abstract][Full Text] [Related]
2. MTHFR 677C->T genotype is associated with folate and homocysteine concentrations in a large, population-based, double-blind trial of folic acid supplementation.
Crider KS; Zhu JH; Hao L; Yang QH; Yang TP; Gindler J; Maneval DR; Quinlivan EP; Li Z; Bailey LB; Berry RJ
Am J Clin Nutr; 2011 Jun; 93(6):1365-72. PubMed ID: 21508090
[TBL] [Abstract][Full Text] [Related]
3. Methylenetetrahydrofolate reductase polymorphism determines the plasma homocysteine-lowering effect of large-dose folic acid supplementation in patients with cardiovascular disease.
Liu CS; Chiang HC; Chen HW
Nutrition; 2004; 20(11-12):974-8. PubMed ID: 15561486
[TBL] [Abstract][Full Text] [Related]
4. 5,10-Methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women.
Fohr IP; Prinz-Langenohl R; Brönstrup A; Bohlmann AM; Nau H; Berthold HK; Pietrzik K
Am J Clin Nutr; 2002 Feb; 75(2):275-82. PubMed ID: 11815318
[TBL] [Abstract][Full Text] [Related]
5. Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study.
Sunder-Plassmann G; Födinger M; Buchmayer H; Papagiannopoulos M; Wojcik J; Kletzmayr J; Enzenberger B; Janata O; Winkelmayer WC; Paul G; Auinger M; Barnas U; Hörl WH
J Am Soc Nephrol; 2000 Jun; 11(6):1106-1116. PubMed ID: 10820175
[TBL] [Abstract][Full Text] [Related]
6. The modifying effect of the MTHFR genotype on the association between folic acid supplementation and pulse wave velocity: Findings from the CSPPT.
Yang X; Zhang M; Song R; Liu C; Huo Y; Qian G
Cardiovasc Ther; 2018 Dec; 36(6):e12473. PubMed ID: 30372582
[TBL] [Abstract][Full Text] [Related]
7. Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial.
Mangoni AA; Sherwood RA; Swift CG; Jackson SH
J Intern Med; 2002 Dec; 252(6):497-503. PubMed ID: 12472909
[TBL] [Abstract][Full Text] [Related]
8. Folic acid improves arterial endothelial function in adults with hyperhomocystinemia.
Woo KS; Chook P; Lolin YI; Sanderson JE; Metreweli C; Celermajer DS
J Am Coll Cardiol; 1999 Dec; 34(7):2002-6. PubMed ID: 10588216
[TBL] [Abstract][Full Text] [Related]
9. Homocysteine lowering by folate-rich diet or pharmacological supplementations in subjects with moderate hyperhomocysteinemia.
Zappacosta B; Mastroiacovo P; Persichilli S; Pounis G; Ruggeri S; Minucci A; Carnovale E; Andria G; Ricci R; Scala I; Genovese O; Turrini A; Mistura L; Giardina B; Iacoviello L
Nutrients; 2013 May; 5(5):1531-43. PubMed ID: 23698160
[TBL] [Abstract][Full Text] [Related]
10. Response of serum and red blood cell folate concentrations to folic acid supplementation depends on methylenetetrahydrofolate reductase C677T genotype: results from a crossover trial.
Anderson CA; Beresford SA; McLerran D; Lampe JW; Deeb S; Feng Z; Motulsky AG
Mol Nutr Food Res; 2013 Apr; 57(4):637-44. PubMed ID: 23456769
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine and Stroke Risk: Modifying Effect of Methylenetetrahydrofolate Reductase C677T Polymorphism and Folic Acid Intervention.
Zhao M; Wang X; He M; Qin X; Tang G; Huo Y; Li J; Fu J; Huang X; Cheng X; Wang B; Hou FF; Sun N; Cai Y
Stroke; 2017 May; 48(5):1183-1190. PubMed ID: 28360116
[TBL] [Abstract][Full Text] [Related]
12. Methylenetetrahydrofolate reductase 677C-->T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial.
Ashfield-Watt PA; Pullin CH; Whiting JM; Clark ZE; Moat SJ; Newcombe RG; Burr ML; Lewis MJ; Powers HJ; McDowell IF
Am J Clin Nutr; 2002 Jul; 76(1):180-6. PubMed ID: 12081832
[TBL] [Abstract][Full Text] [Related]
13. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
[TBL] [Abstract][Full Text] [Related]
14. G1793A polymorphisms in the methylene-tetrahydrofolate gene: effect of folic acid on homocysteine levels.
Melo SS; Persuhn DC; Meirelles MS; Jordao AA; Vannucchi H
Mol Nutr Food Res; 2006 Aug; 50(8):769-74. PubMed ID: 16865747
[TBL] [Abstract][Full Text] [Related]
15. Could genetic analysis be useful in reducing cerebrovascular risk in hypertensive subjects with hyperhomocysteinemia and patent foramen ovale? A 2-year follow-up study.
Mazza A; Montemurro D; L'Erario R; Chinaglia M; Piergentili C; Aggio S; Zanon F; Pastore G; Zanier A; Grassetto G; Zamboni S; Rubello D
Microvasc Res; 2010 Dec; 80(3):545-8. PubMed ID: 20696177
[TBL] [Abstract][Full Text] [Related]
16. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes.
Lin PT; Huang MC; Lee BJ; Cheng CH; Tsai TP; Huang YC
Asia Pac J Clin Nutr; 2008; 17(2):330-8. PubMed ID: 18586656
[TBL] [Abstract][Full Text] [Related]
17. Total homocysteine, folate, and cobalamin, and their relation to genetic polymorphisms, lifestyle and body mass index in healthy children and adolescents.
Huemer M; Vonblon K; Födinger M; Krumpholz R; Hubmann M; Ulmer H; Simma B
Pediatr Res; 2006 Dec; 60(6):764-9. PubMed ID: 17065574
[TBL] [Abstract][Full Text] [Related]
18. Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo-controlled trial.
van Dijk RA; Rauwerda JA; Steyn M; Twisk JW; Stehouwer CD
Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):2072-9. PubMed ID: 11742887
[TBL] [Abstract][Full Text] [Related]
19. Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.
Nakamura T; Saionji K; Hiejima Y; Hirayama H; Tago K; Takano H; Tajiri M; Hayashi K; Kawabata M; Funamizu M; Makita Y; Hata A
Am J Kidney Dis; 2002 May; 39(5):1032-9. PubMed ID: 11979347
[TBL] [Abstract][Full Text] [Related]
20. The C677T MTHFR genotypes influence the efficacy of B9 and B12 vitamins supplementation to lowering plasma total homocysteine in hemodialysis.
Achour O; Elmtaoua S; Zellama D; Omezzine A; Moussa A; Rejeb J; Boumaiza I; Bouacida L; Rejeb NB; Achour A; Bouslama A
J Nephrol; 2016 Oct; 29(5):691-8. PubMed ID: 26559681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
